Table 2.

Recommendations for disease monitoring (from³⁰)

Exam	Frequency
Complete Blood Cell Count	Every 2 weeks until CHR, them every 3 months or as needed
Cytogenetic	At diagnosis, 3 months, 6 months and every 6 months until CCyR, then every 12 months if no molecular test available
	At failure or unexpected myelosuppression
Molecular	Every 3 months until MMR, then every 6 months
Mutation analysis	In case of failure, suboptimal response and before changing 2nd-generation TKI

Abbreviations: CCyR, complete cytogenetic response; CHR, complete hematological response; MMR, major molecular response; TKI, tyrosine kinase inhibitor